QT Imaging Holdings, Inc. (NASDAQ:QTI – Get Free Report) was the target of a large drop in short interest in May. As of May 29th, there was short interest totaling 233,079 shares, a drop of 53.0% from the May 14th total of 495,661 shares. Based on an average daily volume of 54,372 shares, the short-interest ratio is currently 4.3 days. Approximately 2.7% of the shares of the stock are short sold.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on QTI. Wall Street Zen raised shares of QT Imaging to a “hold” rating in a research note on Saturday, May 16th. Zacks Research upgraded QT Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold”.
Check Out Our Latest Analysis on QT Imaging
QT Imaging Trading Down 4.7%
QT Imaging (NASDAQ:QTI – Get Free Report) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.11). The business had revenue of $6.53 million during the quarter, compared to analysts’ expectations of $6.45 million. QT Imaging had a negative net margin of 58.93% and a negative return on equity of 4,220.38%. As a group, analysts anticipate that QT Imaging will post -0.59 EPS for the current fiscal year.
QT Imaging Company Profile
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
Featured Stories
- Five stocks we like better than QT Imaging
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
